Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Intra-Cellular Therapies Inc (ITCI)

  • Event
  • Aug. 09, 2022, 11:38 UTC
  • 22
  • 1 comments

(10% Negative) Intra-Cellular Therapies, Inc. (ITCI) Reports Q3 2022 Financial Results

Comment Full text

Black Diamond Therapeutics (BDTX)

  • Event
  • Aug. 09, 2022, 11:26 UTC
  • 23
  • 1 comments

(30% Negative) BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Reports Q3 2022 Financial Results

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • Aug. 09, 2022, 10:21 UTC
  • 22
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K)

Comment Full text

Black Diamond Therapeutics (BDTX)

  • Event
  • Aug. 09, 2022, 00:00 UTC
  • 49
  • 1 comments

(28% Negative) BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Reports 33% Loss Increase for 2022-06-30

Comment Full text

Cogent Biosciences Inc (COGT)

  • Event
  • Aug. 09, 2022, 00:00 UTC
  • 19
  • 1 comments

(75% Positive) Cogent Biosciences, Inc. (COGT) Reports 57% Loss Reduction for 2022-06-30

Comment Full text

Beam Therapeutics Inc (BEAM)

  • Event
  • Aug. 09, 2022, 00:00 UTC
  • 18
  • 1 comments

(42% Neutral) Beam Therapeutics Inc. (BEAM) Reports Net Loss for 2022-06-30

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Event
  • Aug. 09, 2022, 00:00 UTC
  • 32
  • 1 comments

(76% Positive) SYROS PHARMACEUTICALS, INC. (SYRS) Reports Net Loss for 2022-06-30

Comment Full text

Amphastar (AMPH)

  • Event
  • Aug. 08, 2022, 20:23 UTC
  • 24
  • 1 comments

(79% Neutral) Amphastar Pharmaceuticals, Inc. (AMPH) Reports Q3 2022 Financial Results

Comment Full text

Terns Pharmaceuticals Inc (TERN)

  • Event
  • Aug. 08, 2022, 20:19 UTC
  • 23
  • 1 comments

(30% Negative) Terns Pharmaceuticals, Inc. (TERN) Reports Q3 2022 Financial Results

Comment Full text

Inhibrx (INBX)

  • Event
  • Aug. 08, 2022, 20:19 UTC
  • 19
  • 1 comments

(30% Negative) INHIBRX, INC. (INBX) Reports Q3 2022 Financial Results

Comment Full text
  • Previous
  • 123
  • 124
  • 125
  • 126
  • 127
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189146)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin